Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
10.90
-0.15 (-1.36%)
Nov 20, 2024, 4:00 PM EST - Market closed

Avalo Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
0.821.9218.055.46.76.75
Upgrade
Revenue Growth (YoY)
-63.54%-89.34%234.40%-19.42%-0.76%-3.96%
Upgrade
Cost of Revenue
10.169.9525.9950.1225.2411.63
Upgrade
Gross Profit
-9.34-8.02-7.94-44.72-18.54-4.88
Upgrade
Selling, General & Admin
14.6810.313.9124.6619.7611.61
Upgrade
Research & Development
7.295.128.0511.217.261.17
Upgrade
Operating Expenses
21.9715.422237.4128.7614.11
Upgrade
Operating Income
-31.31-23.44-29.94-82.13-47.29-18.99
Upgrade
Interest Expense
--3.42-4.17-2.39--
Upgrade
Interest & Investment Income
2.18---0.050.12
Upgrade
Other Non Operating Income (Expenses)
52.71-0.76-0.02-0.020.41-0.03
Upgrade
EBT Excluding Unusual Items
23.58-27.62-34.13-84.55-46.84-18.9
Upgrade
Merger & Restructuring Charges
---7.5---
Upgrade
Impairment of Goodwill
-3.91-3.91----
Upgrade
Gain (Loss) on Sale of Investments
----5.210.05
Upgrade
Legal Settlements
-----1.6
Upgrade
Other Unusual Items
-----1.26
Upgrade
Pretax Income
-7.97-31.53-41.63-84.55-67.18-15.99
Upgrade
Income Tax Expense
-0.010.010.03-0.2-2.790.28
Upgrade
Earnings From Continuing Operations
-7.96-31.54-41.66-84.35-64.38-16.27
Upgrade
Earnings From Discontinued Operations
----0.030.880.2
Upgrade
Net Income
-7.96-31.54-41.66-84.38-63.5-16.07
Upgrade
Preferred Dividends & Other Adjustments
0.18-----
Upgrade
Net Income to Common
-8.14-31.54-41.66-84.38-63.5-16.07
Upgrade
Shares Outstanding (Basic)
200000
Upgrade
Shares Outstanding (Diluted)
200000
Upgrade
Shares Change (YoY)
2315.84%608.45%8.32%41.86%28.53%64.39%
Upgrade
EPS (Basic)
-3.93-113.58-1062.65-2331.41-2489.12-809.74
Upgrade
EPS (Diluted)
-75.46-113.58-1062.65-2331.41-2489.12-809.74
Upgrade
Free Cash Flow
-36.78-30.84-26.85-71.01-40.6-19.4
Upgrade
Free Cash Flow Per Share
-17.77-111.04-684.81-1961.95-1591.55-977.20
Upgrade
Gross Margin
---43.98%--276.70%-72.28%
Upgrade
Operating Margin
-3818.41%-1218.50%-165.86%-1521.56%-705.99%-281.37%
Upgrade
Profit Margin
-992.07%-1639.50%-230.78%-1563.10%-947.90%-238.10%
Upgrade
Free Cash Flow Margin
-4485.12%-1602.81%-148.72%-1315.39%-606.09%-287.34%
Upgrade
EBITDA
-31.17-23.29-29.77-80.48-45.45-17.54
Upgrade
EBITDA Margin
---164.94%---259.77%
Upgrade
D&A For EBITDA
0.140.160.171.661.841.46
Upgrade
EBIT
-31.31-23.44-29.94-82.13-47.29-18.99
Upgrade
EBIT Margin
---165.86%---281.37%
Upgrade
Revenue as Reported
0.821.9218.055.46.76.75
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.